EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Ligand bias and inverse agonism on 5‐HT 2A receptor‐mediated modulation of G protein activity in post‐mortem human brain

Itziar Muneta-Arrate iD, Patricia Miranda-Azpiazu iD, Igor Horrillo iD, Rebeca Diez-Alarcia iD, J Javier Meana iD

British Journal of Pharmacology · 2025-07 · 182 (14) · 3320-3335

DOI: 10.1111/bph.16368 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Pharmacology, online erschienen am 21.04.2024. Verfasst von Itziar Muneta-Arrate und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain. Hauptthemen laut MEDLINE: Receptor, Serotonin, 5-HT2A, Serotonin 5-HT2 Receptor Agonists, Brain, GTP-Binding Proteins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Spanish R+D+i Program, European Regional Development Funds, Basque Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Purpose Whereas biased agonism on the 5‐HT 2A receptor has been ascribed to hallucinogenic properties of psychedelics, no information about biased inverse agonism on this receptor is available. In schizophrenia, increased 5‐HT 2A receptor constitutive activity has been suggested, highlighting the therapeutic relevance of inverse agonism. This study characterized the modulation of G protein activity promoted by different drugs, commonly considered as 5‐HT 2A receptor antagonists, in post‐mortem human brain cortex. Experimental Approach Modulation of [ 35 S]GTPγS binding to different subtypes of Gα proteins exerted by different 5‐HT 2A receptor drugs was determined by scintillation proximity assays in brain from human, WT and 5‐HT 2A receptor KO mice. Key Results MDL‐11,939 was the only drug having no effect on the basal activity of 5‐HT 2A receptor. Altanserin and pimavanserin decreased basal activation of G i1 , but not G q/11 proteins. This effect was blocked by MDL‐11,939 and absent in 5‐HT 2A receptor KO mice. Volinanserin showed 5‐HT 2A receptor‐mediated inverse agonism both on G i1 and G q/11 proteins. Ketanserin exhibited 5‐HT 2A receptor partial agonism exclusively on G q/11 proteins. On the other hand, eplivanserin and nelotanserin displayed inverse agonism on G q/11 and/or G i1 proteins, which was insensitive to MDL‐11,939 and was present in KO mice suggesting a role for another receptor. Conclusion and Implications The results reveal the existence of constitutively active 5‐HT 2A receptors in human pre‐frontal cortex and demonstrate different pharmacological profiles of various 5‐HT 2A receptor drugs previously considered antagonists. These findings indicate that altanserin and pimavanserin possess biased inverse agonist profile towards 5‐HT 2A receptor activation of G i1 proteins. LINKED ARTICLES This article is part of a themed issue Complexity of GPCR Modulation and Signaling (ERNST). To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v182.14/issuetoc

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Serotonin, 5-HT2ASerotonin 5-HT2 Receptor AgonistsBrainGTP-Binding ProteinsHumansAnimalsMice, KnockoutLigandsMaleMiceDrug Inverse AgonismFemaleMice, Inbred C57BLSerotonin 5-HT2 Receptor AntagonistsMiddle AgedAgedAutopsyPiperidines

Stichwörter der Autor:innen

5‐HT2A receptorG protein[35S]GTPγSconstitutive activityfunctional selectivityinverse agonismpost‐mortem brain

Substanzen

Receptor, Serotonin, 5-HT2ALigandsSerotonin 5-HT2 Receptor AgonistsGTP-Binding ProteinsSerotonin 5-HT2 Receptor AntagonistsPiperidines

Autor:innen und Institutionen

  • Department of Pharmacology, University of the Basque Country UPV/EHU, Leioa, Spain.
  • Centro de Investigación Biomédica en Red de Salud Mental CIBERSAM, ISCIII, Leioa, Spain.
  • Current address: Department of Basic Neuroscience, Medical Faculty, University of Geneva, Geneva, Switzerland.
  • Biobizkaia Health Research Institute, Barakaldo, Spain.

ORCID-Profile: Itziar Muneta-Arrate, Patricia Miranda-Azpiazu, Igor Horrillo, Rebeca Diez-Alarcia, J Javier Meana

Förderung

  • Spanish R+D+i Program
  • European Regional Development Funds
  • Basque Government
  • University of the Basque Country
  • Eranet Neuron Program: PSYBIAS
  • COST Action CA18133 European Research Network on Signal Transduction (ERNEST)
  • Eusko Jaurlaritza
  • Euskal Herriko Unibertsitatea

Zitieren

APA

Muneta-Arrate, I., Miranda-Azpiazu, P., Horrillo, I., Diez-Alarcia, R., & Meana, J. J. (2025). Ligand bias and inverse agonism on 5‐HT 2A receptor‐mediated modulation of G protein activity in post‐mortem human brain. British Journal of Pharmacology, 182(14), 3320-3335. https://doi.org/10.1111/bph.16368

Vancouver

Muneta-Arrate I, Miranda-Azpiazu P, Horrillo I, Diez-Alarcia R, Meana JJ. Ligand bias and inverse agonism on 5‐HT 2A receptor‐mediated modulation of G protein activity in post‐mortem human brain. British Journal of Pharmacology. 2025;182(14):3320-3335. doi:10.1111/bph.16368

BibTeX
@article{MunetaArrate2025,
  author = {Muneta-Arrate, Itziar and Miranda-Azpiazu, Patricia and Horrillo, Igor and Diez-Alarcia, Rebeca and Meana, J Javier},
  title = {Ligand bias and inverse agonism on 5‐HT 2A receptor‐mediated modulation of G protein activity in post‐mortem human brain},
  journal = {British Journal of Pharmacology},
  year = {2025},
  volume = {182},
  number = {14},
  pages = {3320--3335},
  doi = {10.1111/bph.16368}
}
Kostenlos starten →